Bill
Bill > HR5539
summary
Introduced
09/18/2023
09/18/2023
In Committee
09/22/2023
09/22/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.
AI Summary
This bill, the Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act), aims to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program. Specifically, it proposes changes to the Social Security Act to ensure that the period when a drug was considered an orphan drug is not counted towards the time limit for the exclusion, even if the drug later treats multiple rare diseases or conditions. This change is intended to encourage the development of orphan drugs by providing additional protections from price negotiation.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (14)
John Joyce (R)*,
Gus Bilirakis (R),
Don Davis (D),
Brian Fitzpatrick (R),
Josh Gottheimer (D),
Kevin Hern (R),
Richard Hudson (R),
Bill Keating (D),
Mariannette Miller-Meeks (R),
Wiley Nickel (D),
Mary Peltola (D),
Scott Peters (D),
Lloyd Smucker (R),
Shri Thanedar (D),
Last Action
Referred to the Subcommittee on Health. (on 09/22/2023)
Bill Topics
Health
- ‐ Regulation of Drug Industry and Pharmacies
- ‐ Treatment of Specific Diseases
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/5539/all-info | 09/19/2023 |
| BillText | https://www.congress.gov/118/bills/hr5539/BILLS-118hr5539ih.pdf | 09/23/2023 |
Loading...